Literature DB >> 3533128

The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.

M B Maltz, D W Davies, C P Lau, J E Creamer, S O Banim, A J Camm.   

Abstract

The effects of oral nitrendipine and oral propranolol, alone and in combination, on AV conduction have been examined in 11 patients with essential hypertension in whom arterial pressure was not adequately controlled despite treatment with thiazide diuretics. The study was performed double-blind. After a drug free period of 1 week, the patients received two 7 day courses of drug therapy after initial control measurements. Five of the eleven patients were randomised to receive nitrendipine 20 mg daily, the other six patients received propranolol (Inderal LA 160 mg daily) for the first week of therapy. During week 2, 10 patients received combined therapy. In the 10 patients who completed the study, oral nitrendipine, given either alone or in combination with oral propranolol, had no significant effect on resting PR, QRS, QT intervals nor on AV conduction as assessed by ambulatory electrocardiography. Propranolol did not affect the resting PR interval but significantly increased PR intervals on the ambulatory ECG recordings during single and combined therapy. However the maximum PR intervals remained within normal limits.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533128      PMCID: PMC1401157          DOI: 10.1111/j.1365-2125.1986.tb02918.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Asystole after verapamil.

Authors:  D Krikler; R Spurrell
Journal:  Br Med J       Date:  1972-05-13

2.  The effects of some organic "calcium antagonists" on calcium influx in presynaptic nerve terminals.

Authors:  D A Nachshen; M P Blaustein
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

3.  Probable adverse interaction between oral metoprolol and verapamil.

Authors:  J N Eisenberg; G D Oakley
Journal:  Postgrad Med J       Date:  1984-10       Impact factor: 2.401

4.  Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension.

Authors:  H O Ventura; F H Messerli; W Oigman; F G Dunn; E Reisin; E D Frohlich
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

5.  Hemodynamic and electrophysiologic effects of verapamil and nifedipine in patients on propranolol.

Authors:  M D Winniford; R V Markham; B G Firth; P Nicod; L D Hillis
Journal:  Am J Cardiol       Date:  1982-10       Impact factor: 2.778

6.  Pharmacological studies of the antihypertensive effect of nitrendipine.

Authors:  K Stoepel; A Heise; S Kazda
Journal:  Arzneimittelforschung       Date:  1981

7.  Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.

Authors:  O de Divitiis; M Petitto; S Di Somma; M Galderisi; B Villari; M Santomauro; S Fazio
Journal:  Arzneimittelforschung       Date:  1985

8.  Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy.

Authors:  J C McGourty; J H Silas; S A Solomon
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

9.  Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol.

Authors:  L Harris; H J Dargie; P G Lynch; C J Bulpitt; D M Krikler
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-17

10.  Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

Authors:  P Lynch; H Dargie; S Krikler; D Krikler
Journal:  Br Med J       Date:  1980-07-19
View more
  4 in total

Review 1.  Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.

Authors:  J N Lessem; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

2.  Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study.

Authors:  P A Soons; A G de Boer; P van Brummelen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

Review 3.  Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  K L Goa; E M Sorkin
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.